LpxC inhibitors (Liaoning University/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences/Southwest Jiaotong University)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameLpxC inhibitors (Liaoning University/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences/Southwest Jiaotong University)
Drug Alias Namehydroxamic acid derivatives (Liaoning University/Shanghai Institute of Materia Medica of the Chinese Academy of Sciences/Southwest Jiaotong University)YDL-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors
TargetsUDP-3-O-acyl-N-acetylglucosamine deacetylase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLiaoning University
China Registration ClassN/A

Develop Information

Active CompaniesLiaoning UniversitySouthwest Jiaotong UniversityShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A